ERBB2 and breast carcinoma: However, DUSP6 mRNA expression was neither a prognostic factor in Luminal B or Basal subtypes, nor across unselected breast cancer patient population (Appendix Fig. S2E), further highlighting the selective connection between DUSP6 and HER2 in breast cancer progression.